Fish Oil Supplementation Versus Gemfibrozil Treatment in Hyperlipidemic NIDDM: A Randomized Crossover Study

Hormone and Metabolic Research

Volumn 28, Issue 5, 1996, Pages 230-236

  Fasching, P ^a   Rohac, Madeleine ^a   Liener, K ^a   Schneider, Barbara ^b   Nowotny, P ^a   Waldhausl W ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Institute for Medical Statistics   (Austria)

Author keywords

Fish Oil; Gemfibrozil; Glucose Tolerance; HbA1c; Hyperlipidemia; Non Insulin Dependent Diabetes Mellitus; Plasma Lipids

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; FATTY ACID; FISH OIL; GEMFIBROZIL; GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERLIPIDEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; CHOLESTEROL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FISH OILS; GEMFIBROZIL; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 0029929069     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979171     Document Type: Article

References (46)

1. American Diabetes Association: Consensus statement: Detection and management of lipid disorders in diabetes. Diabetes Care 16: 828-836 (1993)
2. Armstrong, V. W., D. Seidl: Evaluation of a commercial kit for the determination of LDL cholesterol in serum based on precipitation of LDL with dextran sulfate. Ärztl. Lab. 31: 325-330 (1985)
3. Axelrod, L., J. Camuso, E. Williams, K. Kleinmann, E. Briones, D. Schoenfeld: Effects of a small quantity of n-3 fatty acids on cardiovascular risk factors in NIDDM: A randomized, prospective, double-blind, controlled study. Diabetes Care 17: 37-44 (1994)
4. Bagdade, J. D., W. E. Buchanan, R. A. Levy, P. V. Subbaiah, M. C. Ritter: Effects of n-3 fish oils on plasma lipids, lipoprotein composition, and postheparin lipoprotein lipase in women with IDDM. Diabetes 39: 426-431 (1990)
5. Barbir, M., B. Hunt, S. Kushwaha, A. Kehely, R. Prescot, G. R. Thompson, A. Mitchell, M. Yacoub: Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients. Am. J. Cardiol. 70: 1596-1601 (1992)
6. Bergmayer, H. U. (ed.): Methoden der Enzymatischen Analyse. Vol. 6. Verlag Chemie Weinheim, Germany (1984)
7. Borcelli, U., P. Glas-Greenwalt, V. E. Pollack: Enhancing effect of dietary supplement with n-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb. Res. 39: 307-312 (1985)
8. Borkman, M., D. J. Chisholm, S. M. Furler, L. H. Storlien, E. W. Kraegen, L. A. Simons, C. N. Chesterman: Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38: 1314-1319 (1989)
9. Connor, W. E., M. J. Prince, D. Ullmann, M. Riddle, L. Hatcher, F. E. Smith, D. Wilson: The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann. NY Acad. Sci. 683: 337-340 (1993)
10. Dyerberg, J., H. O. Bang: Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet II: 433-435 (1979)
11. Ernst, E.: Effects of n-3 fatty acids on blood rheology. J. Intern. Med. 225, Suppl. 1: 129-132 (1989)
12. Fasching, P., K. Ratheiser, W. Waldhäusl, M. Rohac, W. Osterrode, P. Nowotny, H. Vierhapper: Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 40: 583-589 (1991)
13. Fasching, P., K. Ratheiser, M. Rohac, P. Nowotny, H. Vierhapper, W. Waldhäusl: Both acute and chronic near-normoglycemia are required to improve insulin resistance in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 346-351 (1993)
14. Felber, J. P., E. Haesler, E. Jequier: Metabolic origin of insulin resistance in obesity with and without Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 1221-1229 (1993)
15. Fontbonnne, A., E. Eschnige, F. combien, L. Richard, P. Ducimetière, N. Thibult, J. M. Warnet, R. Claude, G. E. Rosselen: Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes (Result from the 11-year follow-up of the Paris Prospective Study). Diabetologia 32: 300-304 (1989)
16. Friday, K. E., M. childs, C. Tsunehara, W. Y. Fujimoto, E. L. Bierman, J. W. Ensinck: Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II Diabetes. Diabetes Care 12: 276-281 (1989)
17. Garg, A., S. M. Grundy: Management of dyslipidemia in NIDDM. Diabetes Care 13: 153-169 (1990)
18. Glauber, H., P. Wallace, K. Geiser, G. Brechtel: Adverse metabolic effect of omega-3 fatty acids in non insulin diabetes mellitus. Ann. Intern. Med. 108: 663-668 (1988)
19. Hagre, T. A., B. O. Christophersen: Mechanisms for the serum lipid-lowering effect of n-3 fatty acids. Scand. J. Clin. Lab. Invest. 48: 813-816 (1988)
20. Heine, R. J.: Dietary fish oil and insulin action in humans. Ann. NY Acad. Sci. 683: 110-121 (1993)
21. Hendra, T. J., M. E. Britton, D. R. Roper, D. Wagaine-Twabwe, J. Y. Jeremy, P. Dandona, A. P. Haines, J. S. Yudkin: Effects of fish oil supplements in NIDDM subjects. Controlled study. Diabetes Care 13: 821-829 (1990)
22. Herzberg, G. R., M. Rogerson: The effect of dietary fish oil on muscle and adipose tissue lipoprotein lipase. Lipids 24: 351-353 (1989)
23. Kasim, S. E., B. Stern, S. Khilwani, P. Medeni, S. Baciaowski, K. L. P. McLin: Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients. J. Clin. Endocrinol. Metab. 67: 1-5 (1988)
24. Knapp, H. R., G. A. Fitzgerald: The antihypertensive effects of fish oil. N. Engl. J. Med. 320: 1037-1043 (1989)
25. Kostner, G. M., E. Molinari, P. Pichler: Evaluation of a new HDL 2/guantitation method based on precipitation with polyethyline glycol. Clin. Chem. Acta 148: 139-147 (1985)
26. Kromhout, P., E. B. Bosschieter, C. De Lezenne Coulander: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N. Engl. J. Med. 312: 1205-1209 (1985)
27. Lahdenperä, S., M. Tilly-Kiesi, H. Vuorinen-Markkola, T. Kuusi, M. R. Taskinen: Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with Type 2 diabetes. Diabetes Care 16: 584-592 (1993)
28. Leaf, A., P. C. Weber: Cardiovascular effects of n-3 fatty acids. N. Engl. J. med. 318: 549-557 (1988)
29. Malasanos, T. H., P. W. Stacpoole: Biological effects of n-3 fatty acids in diabetes mellitus. Diabetes Care 12: 1160-1179 (1991)
30. Morgan, W. A., J. Rosenstock, P. Raskin: A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM. Diabetes Care 18: 83-86 (1995)
31. Naito, H. K.: Lipoprotein separations using the TL-100-Tabletop Ultracentrifuge. Application Note DS-693. Beckman Instruments, Inc., Spinco Division, Palo Alto, Calif., USA (1986)
32. Phillipson, B. E., D. R. Rothrock, W. E. Connor, W. S. Harris, D. R. Illingworth: Reduction of plasma lipids, lipoproteins and apo-proteins by dietary fish oils in patients with hypertriglyceridemia. N. Engl. J. Med. 312: 1210-1216 (1985)
33. Randle, P. J., P. B. Garland, C. N. Hales, E. A. Newsholme: The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789 (1963)
34. Reaven, G. M.: Role of insulin resistance in human disease. Diabetes 37: 1595-1607 (1988)
35. Ruston, A. C., C. A. Drevon: Eicosapentaenoic acid inhibits hepatic production of very low density lipoproteins. J. Intern. Med. 225 (Suppl. 1): 31-38 (1989)
36. Schectman, G., S. Kaul, A. H. Kissebah: Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes 37: 1567-1573 (1988)
37. Shen, D. C., M. M. T. Fuh, S. M. Shieh, Y. D. I. Chen, G. M. Reaven: Effect of gemfibrozil treatment in sulfonurea-treated patients with non-insulin dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 73: 503-510 (1991)
38. Stern, M. P., B. D. Mitchell, S. M. Haffner, H. P. Hazuda: Does glycemic control of Type 2 diabetes suffice to control diabetic dyslipidemia? A community perspective. Diabetes Care 15: 638-644 (1992)
39. Storlien, L. H., A. B. Jenkins, D. J. Chisholm, W. S. Pascoe, S. Khouri, E. W. Kraegen: Influene of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and n-3 fatty acids in muscle phospholipid. Diabetes 40: 280-289 (1991)
40. Terano, T., J. A. Salmon, G. A. Higgs, S. Moncada: Eucosapentaenoic acid as a modulator of inflammation: effect on prostaglandin and leukotriene synthesis. Biochem. Pharmacol. 35: 779-785 (1986)
41. Todd, P. A., A. Ward: Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia. Drugs 36: 314-339 (1988)
42. Vinik, A. I., J. A. Colwell, Hyperlipidemia in Diabetes Investigators: Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Diabetes Care 16: 37-44 (1993)
43. Vuorinen-Markkola, H., H. Yki-Järvinen, M. R. Taskinen: Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 161-169 (1993)
44. Waldhäusl, W. K., P. R. Bratusch-Marrain, S. Gasic, A. Korn, P. Nowotny: Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 17: 221-227 (1979)
45. Waldhäusl, W., K. Ratheiser, M. Komjati, P. Nowotny, K. Pirich, H. Vierhapper: Increase of insulin sensitivity and intravenous glucose tolerance by fish oil in healthy man. In: "Health Effects of Fish and Fish Oils". R. K. Chandra (ed.) ARTS Biomedical Publishers & Distributors, St. John's, Newfoundland (1989)
46. WHO Expert Committee on Diabetes Mellitus: Second Report, World Health Organisation (Tech. Rep. Ser. no. 646), Geneva (1980)